Haemoperfusion in Amanita phalloides poisoning. 1995

D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
Department of Pediatrics, University of Istanbul, Cerraphaşa Faculty of Medicine, Turkey.

Amanita phalloides is responsible for about 90 per cent of all fatal cases of mushroom intoxication. The amatoxins, the main toxic component of these fungi, are responsible for gastro-intestinal symptoms as well as hepatic and renal failure. Three brothers with Amanita phalloides poisoning were admitted with gastro-intestinal symptoms beginning 12 h after ingestion. Jaundice, hepatomegaly and neurological symptoms were not present, but liver enzymes were moderately increased. Alfa-amanitin was detected in sera of all patients. All patients underwent charcoal hemoperfusion and two of them had additional hemodialysis along with conservative therapy. Liver enzymes that showed a marked increase on the second day of therapy decreased to normal levels on the 28th day. All of our patients survived. This life saving role of early haemoperfusion in Amanita phalloides poisoning is emphasized.

UI MeSH Term Description Entries
D008297 Male Males
D009145 Mushroom Poisoning Poisoning from ingestion of mushrooms, primarily from, but not restricted to, toxic varieties. Poisoning, Mushroom,Mushroom Poisonings,Poisonings, Mushroom
D002606 Charcoal An amorphous form of carbon prepared from the incomplete combustion of animal or vegetable matter, e.g., wood. The activated form of charcoal is used in the treatment of poisoning. (Grant & Hackh's Chemical Dictionary, 5th ed) Activated Charcoal,Actidose,Actidose-Aqua,Adsorba,Carbomix,Charbon,CharcoAid,CharcoCaps,Charcodote,Formocarbine,Insta-Char,Kohle-Compretten,Kohle-Hevert,Kohle-Pulvis,Kohle-Tabletten Boxo-Pharm,Liqui-Char,Norit,Ultracarbon,Charcoal, Activated
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006464 Hemoperfusion Removal of toxins or metabolites from the circulation by the passing of blood, within a suitable extracorporeal circuit, over semipermeable microcapsules containing adsorbents (e.g., activated charcoal) or enzymes, other enzyme preparations (e.g., gel-entrapped microsomes, membrane-free enzymes bound to artificial carriers), or other adsorbents (e.g., various resins, albumin-conjugated agarose). Hemosorption,Hemoperfusions,Hemosorptions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000545 Amanita A genus of fungi of the family Agaricaceae, order Agaricales; most species are poisonous. Amanitas
D000546 Amanitins Cyclic peptides extracted from carpophores of various mushroom species. They are potent inhibitors of RNA polymerases in most eukaryotic species, blocking the production of mRNA and protein synthesis. These peptides are important in the study of transcription. Alpha-amanitin is the main toxin from the species Amanitia phalloides, poisonous if ingested by humans or animals. Amanitin

Related Publications

D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
November 1978, British medical journal,
D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
January 1969, Voprosy pitaniia,
D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
April 2015, Anales de pediatria (Barcelona, Spain : 2003),
D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
December 1965, Revue medico-chirurgicale des maladies du foie,
D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
February 2011, Clinical toxicology (Philadelphia, Pa.),
D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
January 1979, Intensivmedizinische Praxis,
D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
September 1984, Medicina clinica,
D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
January 1978, Annali dell'Ospedale Maria Vittoria di Torino,
D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
September 1981, Revue medicale de la Suisse romande,
D Y Aji, and S Calişkan, and A Nayir, and A Mat, and B Can, and Z Yaşar, and H Ozşahin, and F Cullu, and L Sever
May 1983, The Western journal of medicine,
Copied contents to your clipboard!